Cite
MLA Citation
David Fitz-Patrick et al.. “Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials.” Modern rheumatology, vol. 29, no. 6, 2019, pp. 1042–1052. http://access.bl.uk/ark:/81055/vdc_100099954089.0x00003b